» Articles » PMID: 26252024

MicroRNA-144 Affects Radiotherapy Sensitivity by Promoting Proliferation, Migration and Invasion of Breast Cancer Cells

Overview
Journal Oncol Rep
Specialty Oncology
Date 2015 Aug 8
PMID 26252024
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy resistance remains a major obstacle for patients with breast cancer. miRNAs are important regulators in many biological processes including proliferation, apoptosis, invasion and metastasis and response to treatment in different types of tumors. Here, we describe the role of miRNA-144 in the regulation of radiotherapy sensitivity, migration and invasion of breast cancer cells. The cell survival rate of breast cancer cells was measured by WST-1 assay after irradiation. The caspase-3/-7 activity and apoptotic proteins were analyzed by Caspase-Glo3/7 assay and western blot analysis, respectively. The migration and invasion of breast cancer cells were evaluated by BD Transwell migration and Matrigel invasion assays. The EMT markers were detected by western blot analysis. We found that overexpression of miR-144 increased the proliferation rate of MDA-MB-231 cells without radiation. Both MDA-MB‑231 and SKBR3 cells exhibited significantly increased radiation resistance after overexpression of miR-144. Meanwhile, the migration and invasion of both MDA-MB-231 and SKBR3 cells were changed by altered miR-144 expression. In addition, the overexpression of miR-144 inhibited E-cadherin expression and promoted Snail expression. miR-144 activated AKT by downregulation of PTEN in breast cancer cells. Our results strongly suggest that miR-144 acts as an important regulator of tumorigenesis and tumor progression of breast cancer. These results indicate that miR-144 might serve as a potential molecular target for breast cancer treatment.

Citing Articles

Non-coding RNAs modulation in breast cancer radioresponse: mechanisms and therapeutic implications.

Moqadami A, Ghafari S, Khalaj-Kondori M Strahlenther Onkol. 2024; .

PMID: 39545960 DOI: 10.1007/s00066-024-02317-4.


Non-coding RNAs as modulators of radioresponse in triple-negative breast cancer: a systematic review.

Tofolo M, Berti F, Nunes-Souza E, Ruthes M, Berti L, Fonseca A J Biomed Sci. 2024; 31(1):93.

PMID: 39354523 PMC: 11445946. DOI: 10.1186/s12929-024-01081-y.


miRNAs in radiotherapy resistance of cancer; a comprehensive review.

Al-Hawary S, Jasim S, Altalbawy F, Kumar A, Kaur H, Pramanik A Cell Biochem Biophys. 2024; 82(3):1665-1679.

PMID: 38805114 DOI: 10.1007/s12013-024-01329-2.


Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review.

To N, Nguyen H, Thiolat A, Liu B, Cohen J, Radosevic-Robin N Breast Cancer Res Treat. 2022; 193(2):265-279.

PMID: 35397079 DOI: 10.1007/s10549-022-06533-3.


Role of non-coding RNAs in response of breast cancer to radiation therapy.

Masoudi-Khoram N, Abdolmaleki P Mol Biol Rep. 2022; 49(6):5199-5208.

PMID: 35217966 DOI: 10.1007/s11033-022-07234-2.